
|Articles|March 3, 2010
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-03-03-2010
- Volume 6
- Issue 3
Pfizer Outlines Postacquisition Manufacturing Strategy
Author(s)Pharmaceutical Technology Editors
Following its $68-billion acquisition of Wyeth, Pfizer is integrating its manufacturing and outsourcing activities (Podcast).
Advertisement
Following its $68-billion acquisition of Wyeth (Madison, NJ), Pfizer (New York) is integrating its manufacturing and outsourcing activities. In a joint
Articles in this issue
over 16 years ago
The Opportunities, Challenges, and Trends in Biomanufacturingover 16 years ago
A Bio View of Outsourcingover 16 years ago
Roundup of Informex 2010Advertisement
Related to this article

How confident is the bio/pharma workforce heading into 2027? PharmTech wants to find out, and we need your input.

PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.

Cole and Jaenisch explain where pharma should keep manual checks, how to vet AI skills in hires, and why self-taught AI risks GMP.

Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.

Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.

Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.

Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Challenges in Oral Delivery of Peptides: Bioavailability
2
AstraZeneca Secures 2 FDA Approvals in Bladder Cancer, Myasthenia Gravis
3
Manufacturing Intelligence: Where Pharma Should Slow AI
4
Neladalkib Accelerated Approval: What ALK Drug Developers Should Know
5

